Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Study Identifier
PCYC-0211
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Solid Tumors (General)
  • Lung Cancer - Non-Small Cell Lung Cancer (NSCLC)
  • Study Drug
  • Motexafin Gadolinium
  • Phase
    Phase 3
    Sex
    Female & Male
    Age
    18+ years

    Protocol Summary

    The primary purpose of the study is to determine if patients with brain metastases from non-small cell lung cancer treated with Motexafin Gadolinium and whole brain radiation therapy retain their neurologic function and ability to think for a longer time compared to patients treated with whole brain radiation therapy alone.

    Study Locations

    Location
    Status
    Location
    Phoenix, Arizona, United States
    Status
    Not applicable
    Location
    Fort Smith, Arkansas, United States
    Status
    Not applicable
    Location
    Little Rock, Arkansas, United States
    Status
    Not applicable
    Location
    Berkeley, California, United States
    Status
    Not applicable
    Location
    Concord, California, United States
    Status
    Not applicable
    Location
    Greenbrae, California, United States
    Status
    Not applicable
    Showing {first} - {last} of {total} Results